• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, August 19, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Adjuvant-free avian influenza vaccines in the works

Bioengineer by Bioengineer
June 21, 2021
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: POSTECH

The avian influenza, an acute viral infectious disease that occurs in poultry such as chickens, ducks, and migratory birds, has been reported to be transmittable to humans. It is difficult to control because it spreads among migratory birds that travel to China, Europe, and elsewhere. Once it is transmitted, it spreads rapidly. Disposing infected livestock is not only costly, but also a cause of serious environmental pollution. This is why vaccines against infectious diseases are imperative. To this, a research team in Korea has recently developed a plant-based, adjuvant-free, recombinant protein vaccine that exhibits a strong immune response.

Professor Inhwan Hwang and Ph.D. candidate Shi-Jian Song of the Department of Life Science at POSTECH – in joint research with Professor Chang Seon Song of Konkuk University, Professor Woe-Yeon Kim of Gyeongsang National University, and Eun-Ju Sohn of Bioapp, Inc. – have developed a multivalent vaccine against a variety of avian influenza viruses that does not require any adjuvant. This research was recently published in Journal of Integrative Plant Biology.

Infectious diseases in humans and animals caused by the influenza virus are occurring unpredictably around the world, seriously affecting human health and economic activities like the livestock industry. Various vaccines have been developed and used so far, but concerns have been raised regarding their safety. In particular, the recombinant vaccines enjoy high biosafety and specificity, but have the weakness of low immunogenicity and high production cost compared to inactivated virus or live attenuated virus vaccines.

To this, the joint research team focused on developing multivalent1 vaccines against various avian influenzas based on green vaccine technology. The researchers fabricated a protein trimer (tHA) using plant cells, just like making immune-stimulating drugs from antigenic spikes (haemagglutinin, HA) attached to the influenza virus. By coating this plant-produced tHA on the surface of the inactivated lactococcus without separation or purification, the researchers succeeded in producing bacteria-like particles (BLPs) that carry antigens.

BLPs (tHAs) developed this way showed strong immune responses in mice and chickens without adjuvants. In addition, injections of a bivalent vaccine with two different formulas2 even led to strong immune response to both antigens. This method shows promise to be produced quickly, economically and safely. In fact, the vaccines from this research were applied for patents and are being commercialized with the goal to advance into China and Southeast Asia, as it has gone through a technology transfer to BioApp Co., Ltd.

“Utilizing the green vaccine technology, we have developed a recombinant protein-based vaccine that is safe from exposure to the virus and more,” explained Professor Inhwan Hwang of POSTECH who led the research. “Various strains appear at the same time for influenzas, and this multivalent vaccine can combat such strains.”

This study was conducted with the support of the Ministry of Trade, Industry and Energy and the National Research Foundation of Korea.

###

Media Contact
Jinyoung Huh
[email protected]

Original Source

https://postech.ac.kr/eng/adjuvant-free-avian-influenza-vaccines-in-the-works/?pageds=1&k=&c=

Related Journal Article

http://dx.doi.org/10.1111/jipb.13141

Tags: BiochemistryBiologyBiomechanics/BiophysicsBiotechnologyForestryGeneticsMedicine/HealthPlant SciencesVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

The large-scale clinical study identified the long-term rebleeding rates and predictive rebleeding factors

Obscure gastrointestinal bleeding: rebleeding rates and rebleeding predictors found

August 19, 2022
Scientists have developed improved methods for generating micro-organospheres (MOS) and have shown that they can be used as patient avatars for studies involving direct viral infection, immune cell penetration and high-throughput therapeutic drug screening - something that is not obtainable with conventional patient-derived models.

Next generation patient avatars: Expanding the possibilities with MicroOrganospheres

August 18, 2022

First in nation: UC San Diego health offers treatment for hereditary amyloidosis

August 18, 2022

Machine learning model predicts fall risk for lower limb amputees with up to 80% accuracy, with implications for future smartphone apps

August 18, 2022
Please login to join discussion

POPULAR NEWS

  • Picture of the horse specimen.

    Ancient DNA clarifies the early history of American colonial horses

    57 shares
    Share 23 Tweet 14
  • Fatigue, headache among top lingering symptoms months after COVID

    40 shares
    Share 16 Tweet 10
  • Chi-Huey Wong awarded Tetrahedron Prize for Creativity in Organic Synthesis

    38 shares
    Share 15 Tweet 10
  • Dogs lying in the middle of the road after sunrise at Kewa Pueblo, in no hurry to start the day

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VaccinesUniversity of WashingtonUrogenital SystemVirologyVehiclesWeather/StormsWeaponryViolence/CriminalsVirusVaccineZoology/Veterinary ScienceUrbanization

Recent Posts

  • Early blood tests predict death, severe disability for traumatic brain injury
  • Obscure gastrointestinal bleeding: rebleeding rates and rebleeding predictors found
  • Collaborations inspired early-career NIH grant that could lead to treatment breakthroughs for a range of medical conditions
  • Novel hypotheses that answer key questions about the evolution of sexual reproduction
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In